Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced its participation in the 2024 Jefferies Global Healthcare Conference in New York, scheduled from June 4-6, 2024.

The company's management will engage in one-on-one meetings with investors and deliver a presentation on June 5 from 8:00 to 8:25 AM Eastern Time.

A live webcast of the session will be accessible via the Investor section of Aurinia's website.

Positive

• Aurinia's participation in a prominent healthcare conference may enhance investor interest and visibility.
• Opportunity for one-on-one meetings with investors could lead to potential partnerships or investments.
• Live webcast availability allows broader reach and transparency in the communication.

Negative

• The announcement lacks detailed financial or clinical data that investors typically find crucial.
• No new product or clinical trial updates were provided, which might be expected by investors awaiting new developments.

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Jefferies Global Healthcare Conference in New York from June 4-6, 2024.

Aurinia management will host one-on-one meetings with investors and will participate in a presentation on Wednesday, June 5, from 8:00 to 8:25 AM Eastern Time. A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found here.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS^® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240530835927/en/

Media and Investor Inquiries:

Andrea Christopher

Corporate Communications and Investor Relations, Aurinia

achristopher@auriniapharma.com

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

What event will Aurinia Pharmaceuticals attend in June 2024?

Aurinia Pharmaceuticals will attend the 2024 Jefferies Global Healthcare Conference in New York from June 4-6, 2024.

When is Aurinia Pharmaceuticals' presentation at the 2024 Jefferies Global Healthcare Conference?

Aurinia Pharmaceuticals' presentation is scheduled for June 5, 2024, from 8:00 to 8:25 AM Eastern Time.

Where can I watch Aurinia Pharmaceuticals' presentation at the 2024 Jefferies Global Healthcare Conference?

A live webcast of Aurinia Pharmaceuticals' presentation will be available on the Investor section of Aurinia's website.

What is the stock symbol for Aurinia Pharmaceuticals?

The stock symbol for Aurinia Pharmaceuticals is AUPH.